Last update :
08/12/2024
Diuretic   Furosemide  
injection
Oral solution
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Asadiur Mexico
Demistec Mexico
Desal Turkey
Diorin Colombia
Diural Denmark, Norway
Diurapid Germany
Diurefur Peru
Diuresal Switzerland
Edemid Croatia, Slovenia, Venezuela
Edenol Mexico
Frusemide Australia, Ireland, New Zealand
Frusix Venezuela
Furesis Finland
Furilan Morocco, Tunisia
Furital Argentina
Furix Denmark, Iceland, Norway, Sweden
Furodiurol Mexico
Furohexal Austria
Furomid Turkey
Furon Austria, Hungary
Furophax Peru
Furorese Germany, Luxembourg
Furosan Mexico
Furoxem Tunisia
Fursemid Germany
Hydroflux Greece
Impugan Sweden
Kolkin Argentina
Lasilix France, Hungary, Japan, Morocco, Poland, Tunisia, United States of America
Lasiphar Egypt
Lasix Argentina, Australia, Austria, Belgium, Brazil, Chile, Colombia, Egypt, Germany, Great Britain, Greece, Italy, Luxembourg, Mexico, Netherlands, New Zealand, Portugal, Republic of South Africa, Saudi Arabia, Switzerland, Turkey
Nacua Venezuela
Oedemex Switzerland
Salex Egypt
Salurin Saudi Arabia, United Arab Emirates
Seguril Spain
Uradex Turkey
Urever Turkey
Stability in solutions   injection   Stability in solutions : Furosemide     
Container Solvent Concentration Temperature Storage Duration of stability References
Polyvinyl chloride Sodium chloride 0,9% 1,2 > 3,2 mg/ml 22°C Protect from light
84 Day
1680
Level of evidence A

Polyvinyl chloride Sodium chloride 0,9% 1,2 > 3,2 mg/ml 22°C Light
7 Day
1680
Level of evidence A

Polyvinyl chloride Sodium chloride 0,9% 1,2 > 3,2 mg/ml 6°C Protect from light
84 Day
1680
Level of evidence A

Polypropylen Syringe Sodium chloride 0,9% 1,0 > 8,0 mg/ml 22°C Protect from light
84 Day
1680
Level of evidence A

Polypropylen Syringe Sodium chloride 0,9% 1,0 > 8,0 mg/ml 22°C Light
7 Day
1680
Level of evidence A

Polypropylen Syringe Sodium chloride 0,9% 1,0 > 8,0 mg/ml 6°C Protect from light
84 Day
1680
Level of evidence A

Polypropylen Syringe Sodium chloride 0,9% 5 mg/ml 20°C Light
24 Hour
4341
Level of evidence A

Polypropylen Syringe Sodium chloride 0,9% 5 mg/ml 4°C Protect from light
35 Day
4341
Level of evidence A

Polypropylen Syringe Glucose 5% 1 mg/ml 25°C Protect from light
96 Hour
3821
Level of evidence D


  Mentions Légales